Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9273136 Fully human anti-human NKG2D monoclonal antibodies

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 31, 2009
0
Date of Patent
March 1, 2016
0
Patent Application Number
13057092
0
Patent Citations Received
‌
US Patent 12129300 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11939384 Antibody variable domains targeting the NKG2D receptor
0
‌
US Patent 11987619 Single-chain chimeric polypeptides and uses thereof
0
‌
US Patent 12018071 Single-chain chimeric polypeptides and uses thereof
0
‌
US Patent 12024545 Methods of treating aging-related disorders
0
‌
US Patent 12115191 Methods of treating age-related and inflammatory diseases
0
‌
US Patent 11672826 Methods of treating aging-related disorders
0
‌
US Patent 11713342 Compositions and methods for targeted cytokine delivery
0
‌
US Patent 11834506 Multi-specific binding proteins that bind NKG2D, CD16, and a tumor-associated antigen for activation of natural killer cells and therapeutic uses thereof to treat cancer
0
‌
US Patent 11884733 Antibody variable domains targeting the NKG2D receptor
0
•••
Patent Inventor Names
Ka Yin Kwong
0
Christoph Rader
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
9273136
0
Patent Primary Examiner
‌
Brad Duffy
0

Find more entities like US Patent 9273136 Fully human anti-human NKG2D monoclonal antibodies

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo